Blocking the action of insulin-like growth Factor I (IGF I) impairs kidney
development in vitro. However, no renal developmental abnormalities have be
en reported in newborn transgenic mice that do not express IGF I (Igf1(-/-)
) mice. Ninety-five percent of Igf1(-/-) mice die immediately following bir
th. Kidney development continues Following birth in rodents. To readdress t
he question of the participation of IGF I in the process of kidney developm
ent, we measured nephron numbers in developed kidneys from lgf1(-/-) mice t
hat survived past birth, and using a second model of kidney development, ch
aracterized the effect of IGF infused into rat hosts on the renal function
of transplanted metanephroi. lgf1(-/-) mice were born with grossly normal k
idneys. At 77 +/- 10 days after birth, lgf1(-/-)mice that survived were app
roximately 28% the weight of wild-type (WT) littermates and had proportiona
lly smaller kidneys, The number of nephrons per kidney was reduced by appro
ximately 20% in lgf1(-/-) mice. Glomerular size was also reduced in lgf1(-/
-) mice. In untreated host rats, neither the size nor insulin clearance of
transplanted metanephroi changed significantly from 12-28 weeks postimplant
ation. The administration of IGF I to hosts did not affect the size of tran
splanted metanephroi measured at 12-16 weeks following implantation. Howeve
r, inulin clearances were increased significantly by the administration of
IGF I to hosts. Our findings 1) indicate that IGF I plays a role in determi
ning nephron number, 2) suggest that it enhances function in developing kid
neys, and 3) establish the potential for the pharmacological use of IGF I t
o enhance the growth and function of transplanted metanephroi. (C) 1999 Wil
ey-Liss, Inc.